Advertisement
U.S. markets open in 9 hours 9 minutes
Advertisement

COMPASS Pathways plc (CMPS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
5.98-0.08 (-1.32%)
At close: 04:00PM EST
6.06 +0.08 (+1.34%)
After hours: 07:48PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Performance Outlook
Previous Close6.06
Open6.03
Bid5.80 x 800
Ask6.10 x 800
Day's Range5.82 - 6.04
52 Week Range5.01 - 11.48
Volume176,062
Avg. Volume446,614
Market Cap370.141M
Beta (5Y Monthly)2.56
PE Ratio (TTM)N/A
EPS (TTM)-2.54
Earnings DateFeb 05, 2024 - Feb 09, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est31.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CMPS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • COMPASS Pathways Plc - American
    FLGT: Lowering target price to $22.00FULGENT GENETICS INC has an Investment Rating of SELL; a target price of $22.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    7 days agoArgus Research
View more
  • GlobeNewswire

    Compass Pathways to participate in upcoming Evercore investor conference

    LONDON, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference at 10:25 am ET on November 30, 2023. A live audio webcast of the fireside chat will be accessible from the “Events” page of the Investors section of the Compass website. The replay of the webcast wi

  • GlobeNewswire

    Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment-resistant depression and launches new research center

    UK sites to participate in part of pivotal phase 3 program following Medicines and Healthcare Regulatory Agency approval of study Research will take place in the UK, including at the newly opened Centre for Mental Health Research and Innovation in London, developed in partnership with South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, Psychology & Neuroscience at King’s College London LONDON, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Com

  • Insider Monkey

    COMPASS Pathways plc (NASDAQ:CMPS) Q3 2023 Earnings Call Transcript

    COMPASS Pathways plc (NASDAQ:CMPS) Q3 2023 Earnings Call Transcript November 4, 2023 Operator: Good day, ladies and gentlemen, and welcome to the COMPASS Pathways Third Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. As a reminder, this call is being recorded. I would now like to introduce your host […]